Lund, Sweden, 16 December 2025. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that GOOD-IDES-02, a global pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) ...
Lund, Sweden, 16 December 2025. Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced that GOOD-IDES-02, a global pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) ...
FAMU-FSU College of Engineering researchers are applying fuel cell technology to new applications like sustainable energy and ...
Researchers have developed a theoretical framework that shows how living cell membranes can generate electricity from ...
Cells may generate their own electrical signals through microscopic membrane motions. Researchers show that active molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback